Syndicate Bio
Syndicate Bio enables personalized healthcare by combining genomic testing and AI to deliver actionable insights for patients and providers. The company offers clinical genomic products including hereditary and somatic cancer sequencing, non-invasive prenatal testing, and pharmacogenomics backed by next-generation sequencing and bioinformatics pipelines. Its Direct by Syndicate Bio platform streamlines test ordering and results delivery, and the Precision54 Clinical Hub supports collaborations with governments, healthcare providers, and industry. Core technologies include genomics, machine learning, proteomics, metabolomics, and cloud-based bioinformatics, and the business operates with a SaaS/subscription model. Syndicate Bio focuses on building diverse human health datasets and advancing precision medicine in underserved African regions to reduce health disparities and accelerate drug discovery.
Syndicate Bio
Syndicate Bio enables personalized healthcare by combining genomic testing and AI to deliver actionable insights for patients and providers. The company offers clinical genomic products including hereditary and somatic cancer sequencing, non-invasive prenatal testing, and pharmacogenomics backed by next-generation sequencing and bioinformatics pipelines. Its Direct by Syndicate Bio platform streamlines test ordering and results delivery, and the Precision54 Clinical Hub supports collaborations with governments, healthcare providers, and industry. Core technologies include genomics, machine learning, proteomics, metabolomics, and cloud-based bioinformatics, and the business operates with a SaaS/subscription model. Syndicate Bio focuses on building diverse human health datasets and advancing precision medicine in underserved African regions to reduce health disparities and accelerate drug discovery.